Top Missouri Biotech Companies (33)
Confluence is a contract research organization providing mechanistic enzymology, target validation, characterization, and more.
Digital health company with holographic AR platform for intraprocedural clinical use.
Wugen is a developer of a novel CAR-T therapy platform intended for T-Cell Malignancies.
GlucanBio, an early stage company that repurposes non-food biomass into high-value chemicals and biomaterials
Partek is a software company that provides easy-to-use genomic data analysis solutions for scientists.
Accuronix Therapeutics is a biotech company that develops drug targeting technology to resolve issues in cancer therapy.
APT Therapeutics is a Biotechnology company located in 4041 Forest Park Ave., St. Louis, MO, United States.
Serving the scientific community since 1925, Labconco Corporation manufactures laboratory equipment, specializing in ventilation products such as chemical fume hoods and blowers, ductless fume enclosures, balance enclosures, HEPA-filtered biological safety cabinets (BSCs), clean benches, glove boxes, and laboratory animal research enclosures. Other product lines include glassware washers, forensic enclosures, centrifugal concentrators, lyophilizers, evaporators, and water purification systems. Custom designed products...
As of September 2014, G-Biosciences management system governing the manufacture of our products is ISO9001:2008 certified. For more details on G-Biosciences biotechnology and life science research products click the products tab. Geno Technology, Inc. was founded in 1994 with a vision to simplify life science research. Our primary goal was to target the key techniques of protein research and find affordable methods...
BioSTL builds regional capacity and fosters collaborative efforts to advance innovation,
NewLeaf Symbiotics develops and commercializes the bacteria found in Pink Pigmented Facultative Methylotrophs.
GreenLight Biosciences is a mission-driven public-benefit corporation using the power of RNA to tackle some of humanity's greatest challenges, including pandemics, rare diseases, biodiversity and climate change.
Pioneering Diagnostics A world leader in the field of in vitro diagnostics for over 55 years, bioMérieux is present in 44 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine...
Tansna Therapeutics is a developer of an oral anticonvulsant agent that reduces seizure frequency in patients with epilepsy.
Readout is a sensor biomarker startup that enables sustained metabolic optimization of patients and self-care consumers with fat oxidation biofeedback in breath. We introduced Biosense in 2020 as a Class 1 medical device for in-home behavior modification. Our digital experience allows "dosing" of ketosis with a patented deep lung sampling technology in a precision nutrition journey from weight loss to...
Bacterioscan offers an instrument for detecting and quantifying bacteria in fluid with on-board incubation.
At NorthStar Medical Radioisotopes, our mission is to provide patients global access to game-changing radiopharmaceuticals. We are a growing, commercial-stage company focused on advancing patient care by providing therapeutic radioisotopes and novel radiopharmaceuticals to detect and treat cancer, and customized radiopharmaceutical development services. Radiopharmaceutical therapy is increasingly important for cancer treatment, and NorthStar is expanding our industry-leading position in developing commercial-scale...
At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and...
C₂N Diagnostics’ vision is to bring Clarity Through Innovation™. It focuses its therapeutic discovery efforts around mechanism-based approaches to prevent or stop the progression of human neurological disorders. Diagnostic efforts revolve around bringing accurate, widely accessible, and cost-effective blood tests to the clinic for the betterment of patient care and brain health monitoring. Its lead commercial product, the PrecivityAD™ blood...
